None

In patients with impaired renal function, dose adjustment may be required based on creatinine clearance. Increased serum creatinine levels were observed in trials evaluating valganciclovir. Valganciclovir is used to prevent a disease called CMV retinitis, which can cause blindness in people who have had an organ transplant. CMV disease can cause serious infections in the body, including lungs and eyes, called CMV retinitis, which can lead to blindness. Valganciclovir works by slowing the growth of cytomegalovirus. It helps prevent the infection from spreading to other parts of the body. Valganciclovir is also used to treat advanced HIV disease (AIDS) with cytomegalovirus retinitis. This drug helps control cytomegalovirus retinitis and reduces the risk of blindness. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.